Health Care Contact Days and Outcomes in Clinical Trials vs Routine Care Among Patients With Non–Small Cell Lung Cancer
In this population-based cohort study, patients receiving systemic therapy as part of trials experienced a lower percentage of contact days, accounted for by greater hospitalization rates in routine practice. Addressing the predominantly outpatient, protocol-mandated visits may represent opportunities to decrease trial-related time toxicity.
Authors
- Brooke E. Wilson (ORCID: https://orcid.org/0000-0001-6557-7298)
- Paul Linh Nguyen (ORCID: https://orcid.org/0000-0003-4268-3973)
- Arjun Gupta (ORCID: https://orcid.org/0000-0002-7062-7584)
- Timothy P. Hanna (ORCID: https://orcid.org/0000-0003-3228-6042)
- Christopher M. Booth (ORCID: https://orcid.org/0000-0002-1353-3653)
Institutions
- University of Minnesota (US)
- Queen's University (CA)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.5033
- Citations
- 6
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 18.79
Funders
- Ontario Ministry of Health and Long-Term Care